Page last updated: 2024-10-24

celiprolol and Cardiomyopathy, Congestive

celiprolol has been researched along with Cardiomyopathy, Congestive in 2 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Research Excerpts

ExcerptRelevanceReference
"In this study, the effect of celiprolol (beta-1-antagonist with beta-2-agonistic activity) on hemodynamic and electrocardiographic parameters of patients with congestive heart failure due to ischemic (iCMP) and non-ischemic (niCMP) origin should be evaluated."5.09Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy. ( Hennersdorf, MG; Perings, C; Vester, EG, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hennersdorf, MG1
Perings, C1
Vester, EG1
Böhm, M1
Schulz, C1
Schwinger, RH1
Erdmann, E1

Trials

1 trial available for celiprolol and Cardiomyopathy, Congestive

ArticleYear
Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy.
    International journal of cardiology, 1999, Mar-15, Volume: 68, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathies; Ca

1999

Other Studies

1 other study available for celiprolol and Cardiomyopathy, Congestive

ArticleYear
Positive inotropic effects due to partial agonistic activity of the beta-adrenoceptor antagonist celiprolol following amplification of cAMP formation in failing human myocardium.
    Journal of cardiovascular pharmacology, 1992, Volume: 20, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dilated; Celiprolol; C

1992